Toronto Dominion Bank Purchases 18,896 Shares of Aurora Cannabis Inc. (NASDAQ:ACB)

Toronto Dominion Bank lifted its holdings in Aurora Cannabis Inc. (NASDAQ:ACB) by 34,356.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,951 shares of the company’s stock after purchasing an additional 18,896 shares during the period. Toronto Dominion Bank’s holdings in Aurora Cannabis were worth $88,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cubist Systematic Strategies LLC acquired a new position in Aurora Cannabis in the second quarter worth about $50,000. Cetera Advisors LLC bought a new stake in shares of Aurora Cannabis in the 1st quarter valued at approximately $59,000. Concurrent Investment Advisors LLC acquired a new position in shares of Aurora Cannabis in the 1st quarter worth approximately $90,000. Baader Bank Aktiengesellschaft lifted its position in shares of Aurora Cannabis by 121.1% during the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the period. Finally, Headlands Technologies LLC acquired a new stake in Aurora Cannabis in the 1st quarter valued at $166,000. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Stock Performance

Shares of NASDAQ:ACB opened at $5.40 on Wednesday. The stock has a market capitalization of $294.55 million, a price-to-earnings ratio of -3.86 and a beta of 1.86. The business’s fifty day moving average price is $6.03 and its two-hundred day moving average price is $5.98. Aurora Cannabis Inc. has a fifty-two week low of $2.84 and a fifty-two week high of $9.35. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.76 and a quick ratio of 2.03.

Aurora Cannabis (NASDAQ:ACB) last announced its earnings results on Wednesday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.24. The business had revenue of $67.27 million during the quarter, compared to analysts’ expectations of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. As a group, analysts predict that Aurora Cannabis Inc. will post -0.37 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.